Kadikoylu Gurhan, Yavasoglu Irfan, Ozkul Ayca, Akyol Ali, Yukselen Vahit, Guney Engin, Bolaman Zahit
Adnan Menderes University Medical Faculty, Divisions of Hematology, 09100 Aydin, Turkey.
Transfus Apher Sci. 2012 Aug;47(1):61-5. doi: 10.1016/j.transci.2012.05.002. Epub 2012 May 14.
Therapeutic apheresis (TA) is used as primary and adjunctive therapy in the treatment of several diseases and syndromes. We retrospectively evaluated the results of therapeutic apheresis (TA) including therapeutic plasma-exchange (TPE), double filtration plasmapheresis (DFPP), therapeutic thrombocytapheresis and leukocytapheresis as 11-year activity during 2000-2011. A total of 845 TA procedures were performed in 114 patients (67 male and 47 female, with mean age 51±17 years). Adverse events (AE) were seen in 8.6% of procedures. None of the patients died from any complication. TA is safely carried out in our center in several diseases which are similar to previous reports.
治疗性血液成分单采术（TA）被用作多种疾病和综合征的主要及辅助治疗方法。我们回顾性评估了2000年至2011年期间为期11年的治疗性血液成分单采术（TA）的结果，包括治疗性血浆置换术（TPE）、双重滤过血浆置换术（DFPP）、治疗性血小板单采术和白细胞单采术。114例患者（67例男性和47例女性，平均年龄51±17岁）共接受了845次TA操作。8.6%的操作出现了不良事件（AE）。没有患者死于任何并发症。在我们中心，TA在几种疾病中安全实施，这与之前的报告相似。
